|
|
|
||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | |||||
Journal of Cell Science, Vol 99, Issue 3 583-586, Copyright © 1991 by Company of Biologists
JOURNAL ARTICLES |
DJ Whitby, MT Longaker, MR Harrison, NS Adzick and MW Ferguson
Department of Cell and Structural Biology, School of Biological Sciences, University of Manchester, UK.
Wound healing is a complex process involving the interaction of many cell types with the extracellular matrix (ECM). Fetal skin wound healing differs from that in the adult in that it occurs rapidly and without scar formation. The mechanisms underlying these differing processes may be related to the fetal environment, the stage of differentiation of the fetal cells or the ECM deposited in the wound. The spatial and temporal distribution of two components of the ECM, fibronectin and tenascin, were studied by immunostaining of cryosections from trunk wounds of fetal and adult sheep. Epithelialisation was complete earlier in the fetal wound than in the adult. The distribution of fibronectin was similar in fetal and adult wounds but tenascin was present earlier in the fetal wound. Fibronectin has several roles in wound healing including acting as a substratum for cell migration and as a mediator of cell adhesion through cell surface integrins. The attachment of fibroblasts to fibronectin is inhibited by tenascin and during development the appearance of tenascin in the ECM of migratory pathways correlates with the initiation of cell migration. Similarly, the appearance of tenascin in healing wounds may initiate cell migration. Tenascin was present in these wounds prior to cell migration and the rapid epithelialisation of fetal wounds may be due to the early appearance of tenascin in the wound.
This article has been cited by other articles:
![]() |
M. Ueno, B. L. Lyons, L. M. Burzenski, B. Gott, D. J. Shaffer, D. C. Roopenian, and L. D. Shultz Accelerated Wound Healing of Alkali-Burned Corneas in MRL Mice Is Associated with a Reduced Inflammatory Signature Invest. Ophthalmol. Vis. Sci., November 1, 2005; 46(11): 4097 - 4106. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. S. Midwood and J. E. Schwarzbauer Tenascin-C Modulates Matrix Contraction via Focal Adhesion Kinase- and Rho-mediated Signaling Pathways Mol. Biol. Cell, October 1, 2002; 13(10): 3601 - 3613. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Noda, H. Minoura, R. Nishiura, N. Toyoda, K. Imanaka-Yoshida, T. Sakakura, and T. Yoshida Expression of Tenascin-C in Stromal Cells of the Murine Uterus During Early Pregnancy: Induction by Interleukin-1{alpha}, Prostaglandin E2, and Prostaglandin F2{alpha} Biol Reprod, December 1, 2000; 63(6): 1713 - 1720. [Abstract] [Full Text] |
||||
![]() |
L. Häkkinen, H. C. Hildebrand, A. Berndt, H. Kosmehl, and H. Larjava Immunolocalization of Tenascin-C, {alpha}9 Integrin Subunit, and {alpha}v{beta}6 Integrin During Wound Healing in Human Oral Mucosa J. Histochem. Cytochem., July 1, 2000; 48(7): 985 - 998. [Abstract] [Full Text] |
||||
![]() |
S.C. Bell, J.H. Pringle, D.J. Taylor, and T.M. Malak Alternatively spliced tenascin-C mRNA isoforms in human fetal membranes Mol. Hum. Reprod., November 1, 1999; 5(11): 1066 - 1076. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Kammerer, T. Schulthess, R. Landwehr, A. Lustig, D. Fischer, and J. Engel Tenascin-C Hexabrachion Assembly Is a Sequential Two-step Process Initiated by Coiled-coil alpha -Helices J. Biol. Chem., April 24, 1998; 273(17): 10602 - 10608. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Belford The Mechanism of Excisional Fetal Wound Repair in Vitro Is Responsive to Growth Factors Endocrinology, September 1, 1997; 138(9): 3987 - 3996. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Clark, H. P. Erickson, and T. A. Springer Tenascin Supports Lymphocyte Rolling J. Cell Biol., May 5, 1997; 137(3): 755 - 765. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Talts, A Weller, R Timpl, M Ekblom, and P Ekblom Regulation of mesenchymal extracellular matrix protein synthesis by transforming growth factor-beta and glucocorticoids in tumor stroma J. Cell Sci., January 6, 1995; 108(6): 2153 - 2162. [Abstract] [PDF] |
||||
![]() |
P. Jones, N Boudreau, C. Myers, H. Erickson, and M. Bissell Tenascin-C inhibits extracellular matrix-dependent gene expression in mammary epithelial cells. Localization of active regions using recombinant tenascin fragments J. Cell Sci., January 2, 1995; 108(2): 519 - 527. [Abstract] [PDF] |
||||
![]() |
A. Canfield and A. Schor Evidence that tenascin and thrombospondin-1 modulate sprouting of endothelial cells J. Cell Sci., January 2, 1995; 108(2): 797 - 809. [Abstract] [PDF] |
||||
![]() |
G.H. Sperber Current Concepts in Embryonic Craniofacial Development Critical Reviews in Oral Biology & Medicine, January 1, 1992; 4(1): 67 - 72. [Full Text] [PDF] |
||||
![]() |
C. S. Swindle, K. T. Tran, T. D. Johnson, P. Banerjee, A. M. Mayes, L. Griffith, and A. Wells Epidermal growth factor (EGF)-like repeats of human tenascin-C as ligands for EGF receptor J. Cell Biol., July 23, 2001; 154(2): 459 - 468. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. S. Jones, R. Meech, D. B. Edelman, R. J. Oakey, and P. L. Jones Prx1 Controls Vascular Smooth Muscle Cell Proliferation and Tenascin-C Expression and Is Upregulated With Prx2 in Pulmonary Vascular Disease Circ. Res., July 20, 2001; 89(2): 131 - 138. [Abstract] [Full Text] [PDF] |
||||